Skip to main content

Table 1 Basic characteristics of participants

From: Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial

 

Empagliflozin group

Linagliptin group

Gender, number (%)

Male

9 (30%)

9 (30%)

Female

21 (70%)

21 (70%)

Age (year), mean(SD)

56.8 (8.15)

60.9 (7.22)

BMI (kg/m2), mean (SD)

30.12 (3.08)

28.39 (3.57)

  1. BMI Body Mass Index
Back to article page

Clinical Diabetes and Endocrinology

ISSN: 2055-8260

Contact us